Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL   4:00:00 PM EDT
16.84
+0.60 (+3.70%)
4:00:01 PM EDT: $16.84 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.51B
Current PEN/A
Forward PE N/A
2yr Forward PE 21.59
See more stats
Estimates Current Quarter
Revenue$26.66 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$16.50
50-Day MA$14.87
200-Day MA$13.41
See more pivots

Avadel Pharmaceuticals plc - ADR Stock, NASDAQ:AVDL

10 Earlsfort Terrace, Block 10-1, 2nd Floor, Dublin, Dublin 02
Ireland
Phone: +353.1.901.5201
Number of Employees: 154

Description

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of� cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.